Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Bennett JE, Stevens GA, Mathers CD, Bonita R et al (2018) NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet 392(10152):1072–1088
2. Ferlay, J., M. Ervik, F. Lam, M. Colombet, et al., Global cancer observatory: cancer today. Int. Agency Res. International Journal of Cancer, 2020: p. 1–12.
3. Hartinger CG, Metzler-Nolte N, Dyson PJ (2012) Challenges and opportunities in the development of organometallic anticancer drugs. Organometallics 31(16):5677–5685
4. Reedijk J (1996) Improved understanding in platinum antitumour chemistry. Chem Commun 7:801–806
5. Sze JH, Raninga PV, Nakamura K, Casey M et al (2020) Anticancer activity of a Gold (I) phosphine thioredoxin reductase inhibitor in multiple myeloma. Redox Biol 28:101310–110321